Blueshift Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Blueshift Asset Management's LMAT Position: Q2 2026 in Review
Blueshift Asset Management opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 3,165 shares worth $304K. The stake represents 0.07% of the portfolio and ranks #370 among its holdings. This is a return to the name: Blueshift Asset Management previously reported a position in LMAT as recently as Q1 2025.
Blueshift Asset Management first reported a position in LMAT in Q1 2025 and has held it in 2 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Blueshift Asset Management held 3,165 shares of LeMaitre Vascular worth $304K as of Q2 2026.
- LeMaitre Vascular was a new Blueshift Asset Management position in Q2 2026.
- LeMaitre Vascular made up 0.07% of Blueshift Asset Management's portfolio in Q2 2026, its #370 holding.
- Blueshift Asset Management first reported a position in LeMaitre Vascular in Q1 2025 and has held it in 2 quarters since.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.